The indication for arterial line filtration (ALF) is to inhibit embolisation during cardiopulmonary bypass. Filtration methods have developed from depth filters to screen filters and from a stand-alone component to an integral part of the oxygenator. For many years, ALF has been a standard adopted by a majority of cardiac centres worldwide. The following review aims to summarize the available evidence in support for ALF and report on its current practice in Europe.
Method:
The principles and application of ALF in Europe was investigated using a survey conducted in 2014. The scientific evidence for ALF was examined by performing a systematic literature search in six different databases, using the following search terms: “Cardiopulmonary bypass AND filters AND arterial”. The primary endpoint was protection against cerebral injury verified by the degree of cerebral embolisation or cognitive tests. The secondary endpoint was improvement of the clinical outcome verified elsewise. Only randomised clinical trials were considered.
Results:
The response rate was 31% (n=112). The great majority (88.5%) of respondents were using ALF, following more than 10 years of experience. Integrated arterial filtration was used by 55%. Of respondents not using ALF, fifty-four percent considered starting using integrated arterial filtration. The systematic literature database search returned 180 unique publications where 82 were specifically addressing ALF in cardiopulmonary bypass. Only four out of the 82 identified publications fulfilled our inclusion criteria. Of these, three were more than 20 years old and based on the use of bubble oxygenation.
Conclusion:
ALF is a standard implemented in a majority of cardiopulmonary bypass procedures in Europe. The level of scientific evidence available in support of current arterial line filtration methods in cardiopulmonary bypass is, however, poor. Large, well-designed, randomised trials are warranted.
ÅbergT.Effect of open heart surgery on intellectual function. Scand J Thorac Cardiovasc Surg1974; 15: 1–63.
2.
SwankRLPorterGA.Disappearance of microemboli transfused into patients during extracorporeal circulation. Transfusion (Paris)1963; 3: 192–197.
3.
OsbornJJSwankRLHillJDAguilarMJGerbodeF.Clinical use of a dacron wool filter during perfusion for open-heart surgery. J Thorac Cardiovasc Surg1970; 60: 575–581.
4.
SolisRNoonGBeallAJrDeBakeyM.Particulate microembolism during cardiac operation. Ann Thorac Surg1974; 17: 332–344.
5.
ClarkREMargrafHWBeauchampRA.Fat and solid filtration in clinical perfusions. Surgery1975; 77: 216–224.
6.
WareJAScottMAHorakJKSolisRT.Platelet aggregation during and after cardiopulmonary bypass: effect of two different cardiotomy filters. Ann Thorac Surg1982; 34: 204–206.
7.
LinkoK.An in vitro comparison of six microaggregate blood filters. Acta Anaesthesiol Scand1979; 23: 603–612.
8.
De SomerF.Impact of oxygenator characteristics on its capability to remove gaseous microemboli. J Extra Corpor Technol2007; 39: 271–273.
9.
KuruszMButlerBD.Bubbles and bypass: an update. Perfusion2004; 19: S49–55.
10.
BakerRABronsonSLDickinsonTA. Report from AmSECT’s International Consortium for Evidence-Based Perfusion: American Society of Extracorporeal Technology Standards and Guidelines for Perfusion Practice: 2013. J Extra Corpor Technol2013; 45: 156–166.
11.
Guidance for Cardiopulmonary Bypass Arterial Line Blood Filter 510(k) Submissions; Final Guidance for Industry and FDA. U.S. Department Of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health. 2000, Feb21.
12.
ShannKGLikoskyDSMurkinJM. An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg2006; 132: 283–290.
13.
LoopFDSzaboJRowlinsonRDUrbanekK.Events related to microembolism during extracorporeal perfusion in man: effectiveness of in-line filtration recorded by ultrasound. Ann Thorac Surg1976; 21: 412–420.
14.
PugsleyWKlingerLPaschalisCTreasureTHarrisonMNewmanS.The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke1994; 25: 1393–1399.
15.
BauerASchaarschmidtJAnastasiadisKCarrelT.Reduced amount of gaseous microemboli in the arterial line of minimized extracorporeal circulation systems compared with conventional extracorporeal circulation. Eur J Cardiothorac Surg2014; 46: 152.
16.
LouSJiBLiuJYuKLongC.Generation, detection and prevention of gaseous microemboli during cardiopulmonary bypass procedure. Int J Artif Organs2011; 34: 1039–1051.
17.
StoneyWSAlfordWCBurrusGRGlassfordDMThomasCS.Air embolism and other accidents using pump oxygenators. Ann Thorac Surg1980; 29: 336–340.
18.
StumpDARogersATHammonJWNewmanSP.Cerebral emboli and cognitive outcome after cardiac surgery. J Cardiothorac Vasc Anesth1996; 10: 113–118.
19.
DoganciSGunaydinSKocakOMYilmazSDemirkilicU.Impact of the intensity of microemboli on neurocognitive outcome following cardiopulmonary bypass. Perfusion2013; 28: 256–262.
JohagenDAppelbladMSvenmarkerS.Can the oxygenator screen filter reduce gaseous microemboli?J Extra Corpor Technol2014; 46: 60–66.
28.
MyersGJVoorheesCHaynesREkeB.Post-arterial filter gaseous microemboli activity of five integral cardiotomy reservoirs during venting: an in vitro study. J Extra Corpor Technol2009; 41: 20–27.
29.
GuanYPalanzoDKunselmanAUndarA.Evaluation of membrane oxygenators and reservoirs in terms of capturing gaseous microemboli and pressure drops. Artif Organs2009; 33: 1037–1043.
30.
KazaAKCopeJTFiserSM. Elimination of fat microemboli during cardiopulmonary bypass. Ann Thorac Surg2003; 75: 555–559.
31.
StanzelRHendersonM.An in vitro evaluation of gaseous microemboli handling by contemporary venous reservoirs and oxygenator systems using EDAC. Perfusion2016; 31: 38-44.
32.
PotgerKCMcMillanDAmbroseM.Microbubble transmission during cardiotomy infusion of a hardshell venous reservoir with integrated cardiotomy versus a softshell venous reservoir with separated cardiotomy: an in vitro comparison. J Extra Corpor Technol2013; 45: 77–85.
33.
SmitJDe VriesAGuYVan OeverenW.Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery. Transfus Sci1999; 20: 151–165.
34.
WhitakerDCNewmanSPStygallJHope-WynneCHarrisonMJWalesbyRK.The effect of leucocyte-depleting arterial line filters on cerebral microemboli and neuropsychological outcome following coronary artery bypass surgery. Eur J Cardiothorac Surg2004; 25: 267–274.
35.
GerrietsTSchwarzNSammerG. Protecting the brain from gaseous and solid micro-emboli during coronary artery bypass grafting: a randomized controlled trial. Eur Heart J2010; 31: 360–368.
36.
GoeritzSSchelkleHReinJ-GUrbanekS.Dynamic bubble trap can replace an arterial filter during cardiopulmonary bypass surgery. Perfusion2006; 21: 367–371.
37.
SchoenburgMKrausBMuehlingA. The dynamic air bubble trap reduces cerebral microembolism during cardiopulmonary bypass. J Thorac Cardiovasc Surg2003; 126: 1455–1460.
38.
MilanoADDodonovMOnoratiF. Pulsatile flow decreases gaseous micro-bubble filtering properties of oxygenators without integrated arterial filters during cardiopulmonary bypass. Interact Cardiovasc Thorac Surg2013; 17: 811–817.
39.
NuszkowskiMMDeutschNJonasRAZurakowskiDMontagueEHoltDW.Randomized trial of the Terumo Capiox® FX05 oxygenator with integral arterial filter versus Terumo Capiox® Baby RX05 and Terumo Capiox® AF02 arterial filter in infants undergoing cardiopulmonary bypass. J Extra Corpor Technol2011; 43: 207–214.
40.
OnoratiFSantiniFRaffinF. Clinical evaluation of new generation oxygenators with integrated arterial line filters for cardiopulmonary bypass. Artif Organs2012; 36: 875–885.
41.
GürsuÖIsbirSAkKGerinFArsanS.Comparison of new technology integrated and nonintegrated arterial filters used in cardiopulmonary bypass surgery: a randomized, prospective, and single blind study. Biomed Res2013; 2013: 529087.
42.
PugsleyWKlingerLPaschalisC. Microemboli and cerebral impairment during cardiac surgery. Vasc Surg1990; 24: 34–43.
43.
ArisASolanesHCamaraMJunquéCEscartinACaralpsJ.Arterial line filtration during cardiopulmonary bypass. Neurologic, neuropsychologic, and hematologic studies. J Thorac Cardiovasc Surg1986; 91: 526–533.
44.
TaggartDBhattacharyaKMestonN. Serum S-100 protein concentration after cardiac surgery: a randomized trial of arterial line filtration. Eur J Cardiothorac Surg1997; 11: 645–649.
45.
HarveyBShannKGFitzgeraldD. International pediatric perfusion practice: 2011 survey results. J Extra Corpor Technol2012; 44: 186–193.
46.
AndersonREHanssonLONilssonOLiskaJSettergrenGVaageJ.Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. Ann Thorac Surg2001; 71: 1512–1517.
47.
BlauthCArnoldJSchulenbergWMcCartneyATaylorK.Cerebral microembolism during cardiopulmonary bypass. Retinal microvascular studies in vivo with fluorescein angiography. J Thorac Cardiovasc Surg1988; 95: 668–676.
48.
PadayacheeTSParsonsSTheoboldRGoslingRGDeverallPB.The effect of arterial filtration on reduction of gaseous microemboli in the middle cerebral artery during cardiopulmonary bypass. Ann Thorac Surg1988; 45: 647–649.
49.
BjörkVOSternliebJJDavenportC.From the spinning disc to the membrane oxygenator for open-heart surgery. Scand J Thorac Cardiovasc Surg1985; 19: 207–216.
50.
RimpiläinenRHautalaNKoskenkariJK. Minimized cardiopulmonary bypass reduces retinal microembolization: a randomized clinical study using fluorescein angiography. Ann Thorac Surg2011; 91: 16–22.
51.
De SomerFMVetranoMRVan BeeckJPVan NootenGJ.Extracorporeal bubbles: a word of caution. Interact Cardiovasc Thorac Surg2010; 10: 995–1001.
52.
Abu-OmarYCifelliAMatthewsPMTaggartDP.The role of microembolisation in cerebral injury as defined by functional magnetic resonance imaging. Eur J Cardiothorac Surg2004; 26: 586–591.
53.
SellmanMIvertTStensvedPHogbergMSembB.Doppler ultrasound estimation of microbubbles in the arterial line during extracorporeal circulation. Perfusion1990; 5: 23–32.
54.
AbergTSvenmarkerSHohnerPHentschelJ.Routine registration of deviations from the norm in cardiac surgery: a potent clinical research tool and quality assurance measure. Eur J Cardiothorac Surg1997; 11: 10–12, 13–16.
55.
MurkinJMNewmanSPStumpDABlumenthalJA.Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg1995; 59: 1289–1295.
56.
RudolphJLSchreiberKACulleyDJ. Measurement of post-operative cognitive dysfunction after cardiac surgery: a systematic review. Acta Anaesthesiol Scand2010; 54: 663–677.
57.
BoiviePHanssonMEngströmKG.Aortic plaque distribution in relation to cross clamp and cannulation procedures during cardiac surgery. Scand Cardiovasc J2007; 41: 120–125.
58.
ClarkREBrillmanJDavisDALovellMRPriceTRMagovernGJ.Microemboli during coronary artery bypass grafting. Genesis and effect on outcome. J Thorac Cardiovasc Surg1995; 109: 249–257 Discussion 25.
59.
HammonJWStumpDAKonND. Risk factors and solutions for the development of neurobehavioral changes after coronary artery bypass grafting. Ann Thorac Surg1997; 63: 1613–1618.
60.
MahannaEPBlumenthalJAWhiteWD. Defining neuropsychological dysfunction after coronary artery bypass grafting. Ann Thorac Surg1996; 61: 1342–1347.
61.
CormackFShipoliniAAwadWI. A meta-analysis of cognitive outcome following coronary artery bypass graft surgery. Neurosci Biobehav Rev2012; 36: 2118–2129.
62.
SvenmarkerSSandströmEKarlssonTAbergT.Is there an association between release of protein S100B during cardiopulmonary bypass and memory disturbances?Scand Cardiovasc J2002; 36: 117–122.
63.
ReinsfeltBRickstenSEZetterbergHBlennowKFredén-LindqvistJWesterlindA.Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery. Ann Thorac Surg2012; 94: 549–555.
64.
DomanskiMJFarkouhMEZakV. Predictors of stroke associated with coronary artery bypass grafting in patients with diabetes mellitus and multivessel coronary artery disease. Am J Cardiol2015; 115: 1382–1388.
65.
BakerRAWillcoxTW.Australian and New Zealand perfusion survey: equipment and monitoring. J Extra Corpor Technol2006; 38: 220–229.
66.
WarrenOJWallaceSde WitKLVincentCDarziAWAthanasiouT.Variations in the application of various perfusion technologies in Great Britain and Ireland–a national survey. Artif Organs2010; 34: 200–205.
67.
SilvayGAmmarTReichDLVela-CantosFJoffeDErginAM.Cardiopulmonary bypass for adult patients: a survey of equipment and techniques. J Cardiothorac Vasc Anesth1995; 9: 420–424.
68.
PrestonTJGomezDOlshoveVFPhillipsAGalantowiczM.Clinical gaseous microemboli assessment of an oxygenator with integral arterial filter in the pediatric population. J Extra Corpor Technol2009; 41: 226–230.
69.
GomezDPrestonTJOlshoveVFPhillipsABGalantowiczME.Evaluation of air handling in a new generation neonatal oxygenator with integral arterial filter. Perfusion2009; 24: 107–112.
